A Study of Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Allergan0 个研究点目标入组 4,812 人开始时间: 2010年11月最近更新: 2012年9月5日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: Allergan
入组人数: 4,812
主要终点: Percentage of Patients With a Reduction in Intraocular Pressure (IOP) ≥ 5mmHg From Baseline

研究概览研究设计入排标准结局指标研究者记录与标识符相似试验

研究概览

简要总结

This is an observational study and will evaluate IOP reduction in newly diagnosed patients with POAG or OHT. All care (including treatment and diagnostic procedures) provided is at the discretion of the participating physicians according to their clinical judgment and the local standard of medical care.

研究设计

研究类型: Observational
观察模型: Case Only
时间视角: Prospective

入排标准

性别: All
接受健康志愿者: 否

入选标准

•Newly diagnosed with primary open angle glaucoma or ocular hypertension

排除标准

未提供

结局指标

主要结局

Percentage of Patients With a Reduction in Intraocular Pressure (IOP) ≥ 5mmHg From Baseline

时间窗: Baseline, 14 Weeks

Percentage of patients with a reduction in IOP≥5 mmHg from baseline. IOP is a measurement of the fluid pressure inside the eye. The minimum reduction of 5 mmHg was evaluated in the eye with the highest pressure at the baseline visit.

次要结局

Percentage of Patients With an IOP Reduction ≥10% From Baseline(Baseline, 14 Weeks)
Percentage of Patients With an IOP Reduction ≥20% From Baseline(Baseline, 14 Weeks)

研究者

发起方

Allergan

申办方类型

Industry

责任方

Sponsor

相似试验

已完成

3 期

A Study of DE-111A on the Treatment of Open Angle Glaucoma or Ocular HypertensionOpen-angle Glaucoma, Ocular Hypertension

NCT03822559Santen Pharmaceutical Co., Ltd.219

Unknown

2 期

Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost TherapyGlaucoma

NCT01426464Nanduri, Padma, M.D., FACS22

已完成

2 期

A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle GlaucomaPrimary Open-Angle Glaucoma (POAG)Ocular Hypertension (OHT)

NCT01917383Inotek Pharmaceuticals Corporation101

已完成

1 期

Study Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular HypertensionGlaucoma and Ocular Hypertension

NCT01687426Eye Therapies, LLC15

已完成

不适用

MINIject in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive MedicationsOpen Angle Glaucoma

NCT03193736iSTAR Medical26